“…Given that chronic smoking is associated with multiple neurobiological abnormalities in "healthy" non-AUD samples (Durazzo et al, 2014b;Durazzo et al, 2016;Durazzo, Meyerhoff, & Murray, 2015;Durazzo, Meyerhoff, & Yoder, 2018;Durazzo, Meyerhoff, Yoder, & Murray, 2017;Duriez, Crivello, & Mazoyer, 2014;Franklin et al, 2014;Fritz et al, 2014;Gallinat & Schubert, 2007;Gons et al, 2011;Hanlon et al, 2016;Kuhn et al, 2012;Schubert, Seifert, Bajbouj, & Gallinat, 2006;Stoeckel, Chai, Zhang, Whitfield-Gabrieli, & Evins, 2016;Sutherland et al, 2016;Zanchi et al, 2015), nvsALC may possess greater neurobiological and neurocognitive resiliency to the adverse consequences of AUD, compared to fsALC and asALC. In addition to chronic cigarette smoking, it is possible that premorbid factors (e.g., genetic risk or resiliency factors), or comorbid factors not assessed in this study [e.g., diet/nutrition, exercise, and subclinical hepatic, pulmonary, cardiac, or cerebrovascular dysfunction (Durazzo, Hutchison, Fryer, Mon, & Meyerhoff, 2012;Fama et al, 2019;Hoefer et al, 2014;Mon et al, 2013;Tessner & Hill, 2010;Zahr, Kaufman, & Harper, 2011;Zahr et al, 2016)] influenced neurocognition in this ALC cohort. Any neurocognitive and neurobiological abnormalities observed in those with AUD following detoxification or after an extended period of abstinence are related to multiple premorbid and/or concurrent biopsychosocial factors, and not solely attributable to chronic and excessive alcohol consumption.…”